期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

68例早发型重度子痫前期临床分析 被引量：1

下载PDF
导出
摘要 目的探讨早发型重度子痫前期保守治疗的可行性及母婴的预后。方法68例早发型重度子痫前期按孕周分为A组(孕20～32周),B组(孕32～34周),C组(晚发型≥34周),比较3组终止妊娠孕周。围产儿预后。产妇并发症情况。分析保守治疗的可行性。结果早发型重度子痫前期保守治疗后不良围产儿预后明显下降,3组新生儿窒息率比较差异具有显著性意义(P<0.05)。围产儿死亡率比较差异具有显著性意义(P<0.05)。3组并发症比较差异具有显著性(P<0.05),A组严重性高于B组,B组严重性高于C组。结论早发型重度子痫前期经恰当的保守治疗能明显改善围产儿预后。
作者 宋淑钦
机构地区 莆田学院附属医院妇产科
出处 《中外医疗》 2008年第34期23-25,共3页 China & Foreign Medical Treatment
关键词 早发型 子痫前期 保守治疗 围产儿 预后
分类号 R714.24 [医药卫生—妇产科学]
  • 相关文献

参考文献5

  • 1杨孜,李蓉,石凌懿,王丽娜,叶蓉华,王荣,黄萍.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40(5):302-305. 被引量：333
  • 2[3]Hnat MD,Sibai BM,Caiitis S,et al.Perinatal outcome in women withrscurrent preeclampsia compared with women who develop preeclampsia as nulliparas[J].Am JObstet Gyn ecol,2002,186(3):422～426.
  • 3[4]Chaang EY,Menard MK,Vemillion ST,et al.The association between hyalinemembrane disease and preeclampsia[J]．Am JObstet Gynecol,2004,191(4):1414～1417.
  • 4廖丽君,贺晶.早发型重度子痫前期的治疗进展[J].国外医学（妇产科学分册）,2007,34(2):140-142. 被引量：17
  • 5[6]COPPER RL,GOLDG RL.CREASY RK,et al.A multicenter study of pretem birth weght and gestational hypertensive-[J].Am J Obstet Gynecol,1993,168(IPtI):78～84.

二级参考文献29

  • 1杨孜,叶蓉华.重度妊娠高血压综合征发生时间与母儿预后的关系[J].北京医科大学学报,1996,28(4):298-300. 被引量：28
  • 2Branch DW, Andres R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol, 1989,73:541-545.
  • 3Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol,1994,171:818-822.
  • 4Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onest, severe pre-eclampsia: maternal outcome. BJOG ,2000,107:1252-1257.
  • 5Cunningham FC, Gant NF, Leveno KJ, eds. Williams Obstetrics. 21st ed. New York: McGraw-Hill ,2001. 569-570.
  • 6Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?Am J Obstet Gynecol, 1999,180:221-225.
  • 7Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol,1998,179:1632-1639.
  • 8Hall DR, Odendaal HJ, Kirsten GF, et al. Expectant management of early onest, severe pre-eclampsia: perinatal outcome. BJOG,2000,107:1258-1264.
  • 9Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol, 1990, 76:1070-1075.
  • 10Withagen M, Wallenburg H, Steegers E, et al. Morbidity and development in childhood of infants born after temporizing treatment of early onset pre-eclampsia[J ]. BJOG, 2005, 112(7): 910-914.

共引文献345

同被引文献14

  • 1杨孜,李蓉,石凌懿,王丽娜,叶蓉华,王荣,黄萍.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40(5):302-305. 被引量：333
  • 2张晓丽,张新宇.早发型重度子痫前期的发病机制研究进展[J].中国现代医药杂志,2007,9(1):141-143. 被引量：7
  • 3Ahramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks gestation : does the HELLP ( hemolysis, elevated liver enzymes, and low platelet count) syndrome matter[ J]. Am J Obstet Gy- necol, 1999, 180(1 Pt 1) : 221 -225.
  • 4Said J, Dekker G. Preeclampsia and thrombophilia [ J ]. Best Pract Res Clin Obstet Gynaecol, 2003, 17(2) : 441 -458.
  • 5Hall DR. Early preeclampsia what proportion of women qualify for expectant management and if not, why not [ J]. Eur J Ob- stet Gynecol Reprod Biol, 2006, 128(1-2): 169-174.
  • 6Murphy DJ, Stirra TM. Mortality and morbidity associated with early onset preeclampsia [ J ]. Hypertens Pregnancy, 2000, 19(2): 221 -231.
  • 7Sibai B, Dekker G, Kupferminc M. Preeclampsia [ J ]. Lancet, 2005, 365(9461): 785-799.
  • 8Withagen MI, Wallenburg HC, Steegers EA, et al. Mor- bidity and development in childhood of infants born after temporizing treatment of early onset preeclampsia [ J ]. BJOG, 2005, 112(7) : 910 -914.
  • 9Coomarasamy A, Honest H, Papaioannou S, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systemic review[ J ]. Obstet Gynecol, 2003, 101 (6) : 1319 - 1332.
  • 10Riyazi N, Leeda M. Low-molecular-weight heparin com- bined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study[J]. Eur J Obstet Gynecol Reprod Biol, 1998, 80 ( 1 ): 49 - 54.

引证文献1

二级引证文献53

中外医疗
2008年 第34期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部